Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

DarioHealth (DRIO) Consolidated Net Income (2016 - 2025)

DarioHealth filings provide 13 years of Consolidated Net Income readings, the most recent being $8.7 million for Q4 2025.

  • On a quarterly basis, Consolidated Net Income fell 42.55% to $8.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$24.0 million, a 33.28% decrease, with the full-year FY2025 number at -$24.0 million, down 33.28% from a year prior.
  • Consolidated Net Income hit $8.7 million in Q4 2025 for DarioHealth, up from -$10.5 million in the prior quarter.
  • In the past five years, Consolidated Net Income ranged from a high of $34.1 million in Q4 2021 to a low of -$22.4 million in Q3 2021.
  • Median Consolidated Net Income over the past 5 years was -$12.7 million (2022), compared with a mean of -$8.0 million.
  • The widest YoY moves for Consolidated Net Income: up 476.32% in 2021, down 330.98% in 2021.
  • DarioHealth's Consolidated Net Income stood at $34.1 million in 2021, then plummeted by 136.99% to -$12.6 million in 2022, then skyrocketed by 173.36% to $9.3 million in 2023, then soared by 63.17% to $15.1 million in 2024, then plummeted by 42.55% to $8.7 million in 2025.
  • The last three reported values for Consolidated Net Income were $8.7 million (Q4 2025), -$10.5 million (Q3 2025), and -$13.0 million (Q2 2025) per Business Quant data.